{"id":"https://openalex.org/A5115842016","orcid":null,"observed_orcids":[],"display_name":"Anna Wilsmann","raw_author_names":["Anna Wilsmann","Wilsmann, Anna"],"full_name":"Anna Wilsmann","works_count":8,"cited_by_count":7,"summary_stats":{"2yr_mean_citedness":0.875,"h_index":2,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5115842016","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I94509681","ror":"https://ror.org/010nsgg66","display_name":"Technische Universit\u00e4t Braunschweig","country_code":"DE","type":"education","lineage":["https://openalex.org/I94509681"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I94509681","ror":"https://ror.org/010nsgg66","display_name":"Technische Universit\u00e4t Braunschweig","country_code":"DE","type":"education","lineage":["https://openalex.org/I94509681"]}],"topics":[{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","count":6,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","count":6,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10939","display_name":"Crystal Structures and Properties","count":6,"subfield":{"id":"https://openalex.org/subfields/2504","display_name":"Electronic, Optical and Magnetic Materials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12458","display_name":"Organometallic Compounds Synthesis and Characterization","count":2,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12458","display_name":"Organometallic Compounds Synthesis and Characterization","value":2.85e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11790","display_name":"N-Heterocyclic Carbenes in Organic and Inorganic Chemistry","value":2.42e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","value":1.04e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","value":4.8e-06,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.8135539889335632},{"id":"115624301","wikidata":"https://www.wikidata.org/wiki/Q895901","display_name":"Crystal structure","score":0.6363000273704529},{"id":"192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","score":0.5195000171661377},{"id":"207114421","wikidata":"https://www.wikidata.org/wiki/Q133900","display_name":"Diffraction","score":0.424699991941452},{"id":"2778572836","wikidata":"https://www.wikidata.org/wiki/Q380933","display_name":"Space (punctuation)","score":0.302700012922287}],"counts_by_year":[{"year":2025,"works_count":8,"oa_works_count":8,"cited_by_count":7}],"display_name_alternatives":["Anna Wilsmann","Wilsmann, Anna"],"block_key":"a wilsmann","works_api_url":"https://api.openalex.org/works?filter=author.id:A5115842016","updated_date":"2026-10-12T12:34:37","created_date":"2025-10-10T00:00:00"}